Carvana (CVNA) stock dropped 6% after announcing a forward split, as investors worry about governance disputes, oil prices, and weakening consumer sentiment.
Browsing: News
ARK Invest sold $27M in Nvidia, Meta, Tesla, and AMD on March 27 while buying Arcturus Therapeutics, continuing Cathie Wood’s week-long tech exit.
Netflix (NFLX) receives mixed analyst ratings after implementing a 10% U.S. price hike. Wall Street consensus shows 22% upside potential ahead.
Boston Scientific (BSX) dropped 8% to 52-week lows as Raymond James cut its price target to $88 on concerns about slowing EP and Watchman device growth.
Alcoa (AA) stock surged 10% Monday after Iranian strikes damaged Gulf aluminium facilities, sparking supply concerns and pushing LME prices up 5%.
BullFrog AI (BFRG) stock soared 101% after securing a commercial deal with a top 5 global pharma company for drug target discovery in depression.
Comparing Micron (MU) and Seagate (STX) as AI hardware investments. Micron hits record margins while Seagate delivers consistent cash flow.
WeRide (WRD) stock jumped 6.1% in premarket trading after Uber disclosed a 5.82% passive stake, holding 56.6 million shares in the robotaxi company.
Nike (NKE) reports Q3 earnings March 31. Analysts expect $11.2B revenue, $0.28 EPS. Stock down 25% in 6 months as China demand remains key focus.
U.S. recession probability jumps to 39.2% in March 2026. Analysis of market valuations, oil prices, and economic forecasts signaling potential downturn.
Bitmine (BMNR) reveals $10.7B holdings including 4.73M ETH tokens (3.92% of supply) generating $177M staking revenue. Stock falls 5.86% despite growth.
Fermi (FRMI) stock plunged 25% as IPO lock-up expired, releasing 32.5M shares. Lost $150M tenant and litigation compound pressure on the REIT.
Jet fuel prices surge to $4.24/gallon after Iran strikes. United Airlines models $175 oil, Spirit warns of collapse, and Asian carriers scramble to cut costs.
Korean AI chip startup Rebellions raises $400M at $2.34B valuation, backed by government funds, as it targets U.S. AI labs and prepares for IPO.
Eli Lilly (LLY) stock gains 0.72% after announcing a $2.75 billion partnership with Insilico Medicine to develop AI-generated pharmaceutical treatments.